Preceding Systemic Chemotherapy for Patients with Pancreatic Ductal Adenocarcinoma with Positive Peritoneal Cytology Provides Survival Benefit Compared with Up-Front Surgery.
Kyohei AriakeMasamichi MizumaFuyuhio MotoiShimpei MaedaTakanori MorikawaMasaharu IshidaHideo OhtsukaShuichi AokiTakayuki MiuraTatsuyuki TakadateKei NakagawaTakashi KameiMichiaki UnnoPublished in: Annals of surgical oncology (2021)
As an initial treatment for PDAC patients with PPC, chemotherapy may lead to a favorable prognosis. Especially, resectable PDAC is associated with a greater chance of improved prognosis. Future studies are required to ascertain whether up-front surgery or preceding chemotherapy should be performed for these patients.
Keyphrases
- locally advanced
- minimally invasive
- coronary artery bypass
- end stage renal disease
- ejection fraction
- chronic kidney disease
- rectal cancer
- newly diagnosed
- squamous cell carcinoma
- peritoneal dialysis
- surgical site infection
- radiation therapy
- current status
- percutaneous coronary intervention
- ultrasound guided
- fine needle aspiration
- liver metastases